Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting

Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting

The paper presents the results of the Osteoarthritis (OA) Expert Council held on September 8, 2019, which was attended by Russian and foreign specialists. The experts considered pharmacological treatment options for OA. The expert meeting resolution states that the treatment of patients with OA shou...

Full description

Bibliographic Details
Main Authors:	A. M. Lila, L. I. Alekseeva, A. R. Babaeva, I. Z. Gaydukova, G. Gandolini, E. V. Zonova, R. Capelli, A. E. Karateev, S. S. Kopenkin, N. A. Martusevich, O. B. Nesmeyanova, E. N. Otteva, F. Rannuе, T. A. Raskina, M. L. Sukhareva, E. A. Taskina, N. V. Chichasova, S. P. Yakupova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2019-10-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/973

Similar Items

Symptomatic delayed-acting drugs (SYSADOA): new applications
by: A. M. Lila, et al.
Published: (2022-05-01)

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY
by: L. I. Alekseeva, et al.
Published: (2018-05-01)

EVALUATION OF THE EFFICACY AND SAFETY OF A GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX IN THE TREATMENT OF KNEE OSTEOARTHRITIS IN PATIENTS WITH PREVIOUS INEFFICIENCY OF SLOW-RELEASE ORAL ANTI-INFLAMMATORY DRUGS (THE MULTICENTER OPEN-LABEL STUDY PRIMULA: USE OF RUMALON® WITH INITIALLY SMALL SUCCESS IN THE TREATMENT OF OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2018-03-01)

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study
by: L. I. Alekseeva, et al.
Published: (2021-02-01)

Resolution of the consensus of the Russian Federation experts on the diagnosis and treatment of osteoarthritis, 2022
by: A. M. Lila, et al.
Published: (2022-12-01)

Multimorbidity in osteoarthritis
by: E. A. Taskina, et al.
Published: (2022-07-01)

MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS. CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS
by: Castillo, JR, et al.
Published: (2014)

Osteoarthritis as an interdisciplinary problem: treatment algorithm for physicians and general practitioners
by: A. M. Lila, et al.
Published: (2021-10-01)

Efficacy of Chondroitin Sulfate in Patients with Knee and Hip Osteoarthritis
by: E. P. Sharapova, et al.
Published: (2021-08-01)

A sound approach to choosing nonsteroidal anti-inflammatory drugs for osteoarthritis
by: E. V. Zonova, et al.
Published: (2018-12-01)

TRENDS OF USE OF DIFFERENT SYSADOA IN PATIENTS WITH OSTEOARTHRITIS: A POPULATION-BASED COHORT STUDY
by: Prieto-Alhambra, D, et al.
Published: (2013)

The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study
by: L. I. Alekseeva, et al.
Published: (2020-06-01)

The place of nonsteroidal anti-inflammatory drugs in the current osteoarthritis guidelines
by: E. A. Taskina, et al.
Published: (2020-05-01)

The сhanges of bone mineral density on the risk of progression of osteoarthritis of the knee
by: N G Kashevarova, et al.
Published: (2019-05-01)

Radiographic diagnosis of erosive hand osteoarthritis
by: D. M. Kudinsky, et al.
Published: (2019-12-01)

Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment
by: L. I. Alekseeva, et al.
Published: (2019-05-01)

Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2020-02-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

OSTEOARTHRITIS: CURRENT CLINICAL CONCEPT AND SOME PROMISING THERAPEUTIC APPROACHES
by: A. E. Karateev, et al.
Published: (2018-03-01)

Expression of genes related to glucose metabolism and joint destruction in the development of diabetes mellitus in patients with osteoarthritis
by: E. V. Chetina, et al.
Published: (2019-03-01)

Efficiency and safety of magnetotherapy in the treatment of osteoarthritis. Expert council (3 june 2020, Moscow)
by: A. E. Karateev, et al.
Published: (2021-01-01)

Comparison of standard radiography and magnetic resonance imaging in hand osteoarthritis
by: D. M. Kudinskii, et al.
Published: (2021-09-01)

Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects
by: I. Yu. Torshin, et al.
Published: (2021-08-01)

Standardised Forms of Chondroitin Sulfate as a Pathogenetic Treatment of Osteoarthritis in the Context of Post-Genomic Studies
by: O. A. Gromova, et al.
Published: (2021-02-01)

Degenerative and inflammatory hand joint changes in osteoarthritis according to magnetic resonance imaging
by: D. M. Kudinsky, et al.
Published: (2020-02-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D<sub>3</sub> in knee osteoarthritis: a resolution of the Expert panel
by: Vadim I. Mazurov, et al.
Published: (2024-01-01)

Safe therapy of osteoarthritis: place of topical nonsteroidal anti-inflammatory drugs
by: N. V. Chichasova, et al.
Published: (2020-07-01)

OSTEOARTHRITIS AND OBESITY
by: E. A. Strebkova, et al.
Published: (2015-10-01)

Molecular mechanisms of pain regulation in patients with osteoarthritis
by: E. V. Chetina, et al.
Published: (2016-10-01)

Chronic back pain as a spinal osteoarthritis manifestation: rationale and practice of symptomatic slow acting drugs for osteoarthritis use
by: A. E. Karateev
Published: (2022-08-01)

NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME
by: L. I. Alexeeva, et al.
Published: (2018-02-01)

Modern approaches to the treatment of osteoarthritis
by: N. V. Chichasova
Published: (2020-05-01)

A MULTICENTER, BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFET OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHRITIS. REPORT 2: THE ASSESSMENT OF THE STRUCTURE-MODIFYING EFFECT OF THE DRUG
by: L. I. Alekseeva, et al.
Published: (2014-06-01)

Current approaches to osteoarthritis phenotyping
by: A. M. Lila, et al.
Published: (2019-05-01)

THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO) ALGORITHM FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IS APPLICABLE TO RUSSIAN CLINICAL PRACTICE: A CONSENSUS STATEMENT OF LEADING RUSSIAN AND ESCEO OSTEOARTHRITIS EXPERTS
by: L. N. Denisov, et al.
Published: (2017-01-01)

EFFICIENCY OF DYNAMIC ELECTRONEUROSTIMULATION IN KNEE OSTEOARTHRITIS: RESULTS OF A MULTICENTER RANDOMIZED STUDY
by: O. M. Lesnyak, et al.
Published: (2015-09-01)

Comparative study of the efficacy and safety of Chondroguard® during its combined (intra-articular and intramuscular) and intramuscular injection in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2018-06-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Efficacy and safety of amtolmetin guacil in the therapy of osteoarthritis and associated dyspepsia in routine clinical practice: agatha
by: L. N. Denisov, et al.
Published: (2018-05-01)